首页 > 最新文献

Critical Reviews in Therapeutic Drug Carrier Systems最新文献

英文 中文
A Review of Anti-Aging Nanoformulations: Recent Developments in Excipients for Nanocosmeceuticals and Regulatory Guidelines. 抗衰老纳米制剂综述:纳米药妆辅料的最新发展和监管指南。
IF 2.7 4区 医学 Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-01-01 DOI: 10.1615/CritRevTherDrugCarrierSyst.2021039544
Vivek Basudkar, Sankalp Gharat, M. Momin, Mihika Shringarpure
Skin aging is the progressive biological process generally characterized by the appearance of wrinkles, age spots, sagging of skin, and dryness. Since skin is an essential part of physical appearance, this has led to increased concerns about skincare. Anti-aging products help in improving the quality and health of the skin by nourishing it. However, due to large particle size they are less efficacious. Nanotechnological approaches for topical anti-aging products have a significant effect on the product performance. Lipidic, polymeric, and metallic nanoparticles have shown potential advantages like enhanced stability and efficacy due to their smaller size. The excipients used in these nanoformulations play an important role in improving the efficacy and shelf-life of the product. The optimal selection of excipients plays a major role in the nanoformulation approach for their enhanced efficacy and stability. For the past three decades the ingredients of natural origin for cosmetic formulations have been widely recognized for being safe and less toxic. The objective of this article is to review the nanoformulations used in anti-aging along with the potential excipients used, currently marketed formulations, and patents filed for cosmetic use. Recent updates related to regulatory aspects of the nanocosmetics have also been highlighted.
皮肤老化是一个渐进的生物过程,通常以皱纹、老年斑、皮肤松弛和干燥为特征。由于皮肤是身体外观的重要组成部分,这导致人们越来越关注皮肤护理。抗衰老产品通过滋养皮肤,帮助改善皮肤质量和健康。然而,由于颗粒尺寸大,它们的效果较差。纳米技术在局部抗衰老产品中的应用对产品性能有显著影响。脂质、聚合物和金属纳米颗粒由于其更小的尺寸而显示出潜在的优势,如增强的稳定性和有效性。这些纳米制剂中使用的赋形剂在提高产品的功效和保质期方面起着重要作用。赋形剂的优化选择对提高纳米制剂的疗效和稳定性起着重要作用。在过去的三十年中,化妆品配方中的天然成分已被广泛认为是安全和毒性较小的。本文的目的是回顾用于抗衰老的纳米配方以及潜在的赋形剂,目前市场上的配方,以及用于化妆品的专利申请。最近有关纳米化妆品监管方面的更新也得到了强调。
{"title":"A Review of Anti-Aging Nanoformulations: Recent Developments in Excipients for Nanocosmeceuticals and Regulatory Guidelines.","authors":"Vivek Basudkar, Sankalp Gharat, M. Momin, Mihika Shringarpure","doi":"10.1615/CritRevTherDrugCarrierSyst.2021039544","DOIUrl":"https://doi.org/10.1615/CritRevTherDrugCarrierSyst.2021039544","url":null,"abstract":"Skin aging is the progressive biological process generally characterized by the appearance of wrinkles, age spots, sagging of skin, and dryness. Since skin is an essential part of physical appearance, this has led to increased concerns about skincare. Anti-aging products help in improving the quality and health of the skin by nourishing it. However, due to large particle size they are less efficacious. Nanotechnological approaches for topical anti-aging products have a significant effect on the product performance. Lipidic, polymeric, and metallic nanoparticles have shown potential advantages like enhanced stability and efficacy due to their smaller size. The excipients used in these nanoformulations play an important role in improving the efficacy and shelf-life of the product. The optimal selection of excipients plays a major role in the nanoformulation approach for their enhanced efficacy and stability. For the past three decades the ingredients of natural origin for cosmetic formulations have been widely recognized for being safe and less toxic. The objective of this article is to review the nanoformulations used in anti-aging along with the potential excipients used, currently marketed formulations, and patents filed for cosmetic use. Recent updates related to regulatory aspects of the nanocosmetics have also been highlighted.","PeriodicalId":50614,"journal":{"name":"Critical Reviews in Therapeutic Drug Carrier Systems","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67437535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Receptor-Targeted Surface-Engineered Nanomaterials for Breast Cancer Imaging and Theranostic Applications. 受体靶向表面工程纳米材料在乳腺癌成像和治疗中的应用。
IF 2.7 4区 医学 Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-01-01 DOI: 10.1615/CritRevTherDrugCarrierSyst.2022040686
Javed Ahmad, Md Rizwanullah, Teeja Suthar, Hassan A Albarqi, Mohammad Zaki Ahmad, Parameswara Rao Vuddanda, Mohammad Ahmed Khan, Keerti Jain

Breast cancer is one of the most frequently diagnosed cancers in women and the major cause of worldwide cancer-related deaths among women. Various treatment strategies including conventional chemotherapy, immunotherapy, gene therapy, gene silencing and deliberately engineered nanomaterials for receptor mediated targeted delivery of anticancer drugs, antibodies, and small-molecule inhibitors, etc are being investigated by scientists to combat breast cancer. Smartly designed/fabricated nanomaterials are being explored to target breast cancer through enhanced permeation and retention effect; and also, being conjugated with suitable ligand for receptor-mediated endocytosis to target breast cancer for diagnostic, and theranostic applications. These receptor-targeted nanomedicines have shown efficacy to target specific tumor tissue/cells abstaining the healthy tissues/cells from cytotoxic effect of anticancer drug molecules. In the last few decades, theranostic nanomedicines have gained much attention among other nanoparticle systems due to their unique ability to deliver chemotherapeutic as well as diagnostic agents, simultaneously. Theranostic nanomaterials are emerging as novel paradigm with ability for concurrent delivery of imaging (with contrasting agents), targeting (with biomarkers), and anticancer therapeutics with one delivery system (as cancer theranostics) and can transpire as promising strategy to overcome various hurdles for effective management of breast cancer including its most aggressive form, triple-negative breast cancer.

乳腺癌是妇女中最常诊断的癌症之一,也是全世界妇女癌症相关死亡的主要原因。科学家们正在研究各种治疗策略,包括传统的化疗、免疫治疗、基因治疗、基因沉默和精心设计的纳米材料,用于受体介导的抗癌药物、抗体和小分子抑制剂的靶向递送,以对抗乳腺癌。人们正在探索巧妙设计/制造的纳米材料,通过增强渗透和保留效果来靶向乳腺癌;同时,与合适的配体结合,用于受体介导的内吞作用,用于乳腺癌的诊断和治疗应用。这些受体靶向纳米药物已显示出靶向特定肿瘤组织/细胞的功效,使健康组织/细胞免受抗癌药物分子的细胞毒性作用。在过去的几十年里,治疗性纳米药物由于其同时提供化疗和诊断药物的独特能力而在其他纳米颗粒系统中获得了广泛的关注。治疗纳米材料正在成为一种新的范例,具有同时传递成像(与造影剂)、靶向(与生物标志物)和抗癌治疗(与癌症治疗一样)的能力,并且可以作为一种有希望的策略来克服有效管理乳腺癌的各种障碍,包括最具侵略性的三阴性乳腺癌。
{"title":"Receptor-Targeted Surface-Engineered Nanomaterials for Breast Cancer Imaging and Theranostic Applications.","authors":"Javed Ahmad,&nbsp;Md Rizwanullah,&nbsp;Teeja Suthar,&nbsp;Hassan A Albarqi,&nbsp;Mohammad Zaki Ahmad,&nbsp;Parameswara Rao Vuddanda,&nbsp;Mohammad Ahmed Khan,&nbsp;Keerti Jain","doi":"10.1615/CritRevTherDrugCarrierSyst.2022040686","DOIUrl":"https://doi.org/10.1615/CritRevTherDrugCarrierSyst.2022040686","url":null,"abstract":"<p><p>Breast cancer is one of the most frequently diagnosed cancers in women and the major cause of worldwide cancer-related deaths among women. Various treatment strategies including conventional chemotherapy, immunotherapy, gene therapy, gene silencing and deliberately engineered nanomaterials for receptor mediated targeted delivery of anticancer drugs, antibodies, and small-molecule inhibitors, etc are being investigated by scientists to combat breast cancer. Smartly designed/fabricated nanomaterials are being explored to target breast cancer through enhanced permeation and retention effect; and also, being conjugated with suitable ligand for receptor-mediated endocytosis to target breast cancer for diagnostic, and theranostic applications. These receptor-targeted nanomedicines have shown efficacy to target specific tumor tissue/cells abstaining the healthy tissues/cells from cytotoxic effect of anticancer drug molecules. In the last few decades, theranostic nanomedicines have gained much attention among other nanoparticle systems due to their unique ability to deliver chemotherapeutic as well as diagnostic agents, simultaneously. Theranostic nanomaterials are emerging as novel paradigm with ability for concurrent delivery of imaging (with contrasting agents), targeting (with biomarkers), and anticancer therapeutics with one delivery system (as cancer theranostics) and can transpire as promising strategy to overcome various hurdles for effective management of breast cancer including its most aggressive form, triple-negative breast cancer.</p>","PeriodicalId":50614,"journal":{"name":"Critical Reviews in Therapeutic Drug Carrier Systems","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40649106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Exploration of 3D Printing of Anti-Infective Urinary Catheters: Materials and Approaches to Combat Catheter-Associated Urinary Tract Infections (CAUTIs) - A Review. 3D打印抗感染导尿管的探索:抗导尿管相关尿路感染(CAUTIs)的材料和方法综述
IF 2.7 4区 医学 Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-01-01 DOI: 10.1615/CritRevTherDrugCarrierSyst.2022040452
Archana Menon, Rubini Durairajan, Ramyadevi Durai, Nithyanand Paramasivam, VedhaHari B Narayanan

Three-dimensional (3D) printing is a pioneering technology that has gained increased popularity in the fields of tissue engineering, drug design, drug delivery systems and biomedical devices. Thus, it enables us to explore this technique for fabricating 3D-printed catheters. Owing to its enhanced productivity and cost-efficiency, this technique can be utilized to fabricate any material for manufacturing or designing catheters with antimicrobial properties. From 1930s, Foley's catheter had been widely used to drain the urinary bladder of patients with impaired bladder function. Despite the complications like catheter-associated urinary tract infections (CAUTIs), kidney damage, chronic infections, encrustations and personal discomfort during inflation of the balloon, Foley's catheter was used universally without any changes in product design. Currently, marketed catheters have been reported for reducing CAUTI, but the prevention of limitations by coating drugs onto the catheter is very expensive. Altering the physical properties of the catheter by biopolymer blend might ease the discomfort. Thus, new technologies have to be adopted to manufacture ideal catheters that are biocompatible and provide antimicrobial and anti-fouling properties. Herein, we provide an overview of 3D printing techniques along with different materials opted for manufacturing catheters to overcome the existing challenges and limitations.

三维(3D)打印是一项开创性的技术,在组织工程、药物设计、药物输送系统和生物医学设备领域越来越受欢迎。因此,它使我们能够探索这种制造3d打印导管的技术。由于其提高的生产率和成本效益,该技术可用于制造或设计具有抗菌性能的导管的任何材料。从20世纪30年代开始,Foley导尿管被广泛用于膀胱功能受损患者的膀胱引流。尽管在气囊充气过程中存在导管相关性尿路感染(CAUTIs)、肾脏损害、慢性感染、结皮和个人不适等并发症,Foley的导尿管在没有改变产品设计的情况下被普遍使用。目前,市场上的导管已被报道用于减少CAUTI,但通过在导管上涂覆药物来预防局限性是非常昂贵的。通过生物聚合物混合物改变导管的物理特性可能会减轻这种不适。因此,必须采用新技术来制造具有生物相容性并提供抗菌和抗污染性能的理想导管。在这里,我们提供了3D打印技术的概述,以及用于制造导管的不同材料,以克服现有的挑战和限制。
{"title":"Exploration of 3D Printing of Anti-Infective Urinary Catheters: Materials and Approaches to Combat Catheter-Associated Urinary Tract Infections (CAUTIs) - A Review.","authors":"Archana Menon,&nbsp;Rubini Durairajan,&nbsp;Ramyadevi Durai,&nbsp;Nithyanand Paramasivam,&nbsp;VedhaHari B Narayanan","doi":"10.1615/CritRevTherDrugCarrierSyst.2022040452","DOIUrl":"https://doi.org/10.1615/CritRevTherDrugCarrierSyst.2022040452","url":null,"abstract":"<p><p>Three-dimensional (3D) printing is a pioneering technology that has gained increased popularity in the fields of tissue engineering, drug design, drug delivery systems and biomedical devices. Thus, it enables us to explore this technique for fabricating 3D-printed catheters. Owing to its enhanced productivity and cost-efficiency, this technique can be utilized to fabricate any material for manufacturing or designing catheters with antimicrobial properties. From 1930s, Foley's catheter had been widely used to drain the urinary bladder of patients with impaired bladder function. Despite the complications like catheter-associated urinary tract infections (CAUTIs), kidney damage, chronic infections, encrustations and personal discomfort during inflation of the balloon, Foley's catheter was used universally without any changes in product design. Currently, marketed catheters have been reported for reducing CAUTI, but the prevention of limitations by coating drugs onto the catheter is very expensive. Altering the physical properties of the catheter by biopolymer blend might ease the discomfort. Thus, new technologies have to be adopted to manufacture ideal catheters that are biocompatible and provide antimicrobial and anti-fouling properties. Herein, we provide an overview of 3D printing techniques along with different materials opted for manufacturing catheters to overcome the existing challenges and limitations.</p>","PeriodicalId":50614,"journal":{"name":"Critical Reviews in Therapeutic Drug Carrier Systems","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40717501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oral Dispersible Films from Product Development to End-User Acceptability: A Review. 口服分散膜从产品开发到最终用户可接受性:综述。
IF 2.7 4区 医学 Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-01-01 DOI: 10.1615/CritRevTherDrugCarrierSyst.2021036885
Qurrat-Ul-Ain Khan, Muhammad Irfan Siddique, Muhammad Sarfraz, Khurram Rehman, Muhammad Farhan Sohail, Haliza Katas

Orodispersible films (ODFs) have served as an emerging platform for the delivery of drugs in a convenient way. They have numerous advantages, the significant one is simplicity of administration for special populations such as pediatric and geriatric as well as patients with swallowing difficulty. Besides, the advantages include accurate dosing and fast action. The ODFs are efficiently designed with detailed knowledge of drug and polymers as well as a suitable selection of method. Many conventional and advance formulation strategies have been used for the development of ODFs. The biopharmaceutical concerns of active pharmaceutical ingredients (APIs) are given in this review in light of the fact that ODFs can be utilized to increase the bioavailability of APIs. The basic critical issues such as good mechanical properties, water solubility of the API and taste masking are very important to be considered during the development of ODFs. The knowledge of critical quality concerns of ODFs will be helpful in the future development of ODF. As ODFs remain in the mouth until complete degradation, taste, texture and mouth-feel are the qualities that in all respects liable for acceptability of the patient. An assortment of packaging choices is also accessible for ODFs. This review focuses on the different critical concerns of ODF related to composition, bio-pharmaceutical, manufacturing, quality tests, packaging and acceptability. Additionally, potential barriers in the ODFs development are discussed in details. Therefore, this review is an informative bundle of ODFs concerns from the product development stage to the end-user acceptability.

孔分散膜(odf)已成为一个新兴的平台,以一种方便的方式输送药物。它们有许多优点,最重要的是对于特殊人群,如儿童和老年人以及吞咽困难的患者,使用简单。此外,它还具有给药准确、起效快等优点。odf是有效地设计与药物和聚合物的详细知识,以及合适的方法选择。许多传统和先进的配方策略已被用于发展odf。鉴于odf可用于提高原料药的生物利用度,本文综述了活性药物成分(api)的生物制药问题。良好的机械性能、原料药的水溶性和掩味性等基本关键问题是odf开发过程中需要考虑的重要问题。了解ODF的关键质量问题将有助于ODF的未来发展。由于odf在完全降解之前一直留在口腔中,所以味道、质地和口感是患者在各方面都能接受的品质。odf还可以使用各种包装选择。本文综述了ODF在组成、生物制药、生产、质量检测、包装和可接受性方面的不同关键问题。此外,还详细讨论了odf开发中的潜在障碍。因此,这个审查是一个从产品开发阶段到最终用户可接受性的odf关注点的信息包。
{"title":"Oral Dispersible Films from Product Development to End-User Acceptability: A Review.","authors":"Qurrat-Ul-Ain Khan,&nbsp;Muhammad Irfan Siddique,&nbsp;Muhammad Sarfraz,&nbsp;Khurram Rehman,&nbsp;Muhammad Farhan Sohail,&nbsp;Haliza Katas","doi":"10.1615/CritRevTherDrugCarrierSyst.2021036885","DOIUrl":"https://doi.org/10.1615/CritRevTherDrugCarrierSyst.2021036885","url":null,"abstract":"<p><p>Orodispersible films (ODFs) have served as an emerging platform for the delivery of drugs in a convenient way. They have numerous advantages, the significant one is simplicity of administration for special populations such as pediatric and geriatric as well as patients with swallowing difficulty. Besides, the advantages include accurate dosing and fast action. The ODFs are efficiently designed with detailed knowledge of drug and polymers as well as a suitable selection of method. Many conventional and advance formulation strategies have been used for the development of ODFs. The biopharmaceutical concerns of active pharmaceutical ingredients (APIs) are given in this review in light of the fact that ODFs can be utilized to increase the bioavailability of APIs. The basic critical issues such as good mechanical properties, water solubility of the API and taste masking are very important to be considered during the development of ODFs. The knowledge of critical quality concerns of ODFs will be helpful in the future development of ODF. As ODFs remain in the mouth until complete degradation, taste, texture and mouth-feel are the qualities that in all respects liable for acceptability of the patient. An assortment of packaging choices is also accessible for ODFs. This review focuses on the different critical concerns of ODF related to composition, bio-pharmaceutical, manufacturing, quality tests, packaging and acceptability. Additionally, potential barriers in the ODFs development are discussed in details. Therefore, this review is an informative bundle of ODFs concerns from the product development stage to the end-user acceptability.</p>","PeriodicalId":50614,"journal":{"name":"Critical Reviews in Therapeutic Drug Carrier Systems","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39746605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Polymeric Nanoparticles: A Holistic Approach to Combat Tuberculosis. 聚合纳米颗粒:对抗结核病的整体方法。
IF 2.7 4区 医学 Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-01-01 DOI: 10.1615/CritRevTherDrugCarrierSyst.2022039981
Sarita Rani, Ashok Kumar Sharma, Raghu Kasu, Umesh Gupta

The emergence of multidrug-resistant (MDR) and extremely drug resistant (XDR) forms of pulmonary tuberculosis (TB) remains a major health challenge in this advanced era of health science. The longer therapy and higher dose of anti-tubercular drugs (ATDs) increases the patient incompliance at its peak levels of intolerance as well as toxicity. In the recent decades, nanoparticulate drug delivery has emerged as an excellent venture for the effective treatment of cancer, infectious diseases, brain as well as TB. Currently, encapsulation and conjugation of therapeutics to polymeric nanoparticles (PNPs) is an attractive strategy to enhance the effectivity of chemotherapeutics and minimize the toxic effects associated with ATDs. Various characteristics of nanoparticles (NPs) such as high stability, high loading efficiency, and high carrying capacity gives preference to the NPs over other drug delivery systems. Multiple or dual drug delivery concept is continuously gaining attention as a strict and favourable requirement of anti-TB therapy. The ideal properties of NPs including controlled or sustained drug release from the matrix enhances drug bioavailability with dose reduction and also enhance compliance of TB patients. Natural and synthetic polymers are playing important role in curtailing the side effects of chemotherapeutics. This review extensively highlights the drug delivery approaches of ATDs and emphasized on the importance and application of PNPs to combat TB.

多药耐药(MDR)和极端耐药(XDR)形式肺结核(TB)的出现仍然是这个卫生科学先进时代的主要卫生挑战。抗结核药物(ATDs)治疗时间越长、剂量越高,患者的不依从性和毒性就越高。近几十年来,纳米颗粒给药已经成为一种有效治疗癌症、传染病、脑病和结核病的极好方法。目前,将治疗药物包封和偶联到聚合物纳米颗粒(PNPs)上是一种有吸引力的策略,可以提高化疗药物的有效性,并最大限度地减少与ATDs相关的毒性作用。纳米颗粒(NPs)的各种特性,如高稳定性、高负载效率和高承载能力,使其优于其他药物递送系统。多重或双重给药概念作为抗结核治疗的严格和有利的要求不断受到关注。NPs的理想特性包括从基质中控制或持续释放药物,可随着剂量的减少提高药物的生物利用度,并提高结核病患者的依从性。天然和合成聚合物在减少化疗药物的副作用方面发挥着重要作用。本文综述了ATDs的给药途径,并强调了PNPs在防治结核病中的重要性和应用。
{"title":"Polymeric Nanoparticles: A Holistic Approach to Combat Tuberculosis.","authors":"Sarita Rani,&nbsp;Ashok Kumar Sharma,&nbsp;Raghu Kasu,&nbsp;Umesh Gupta","doi":"10.1615/CritRevTherDrugCarrierSyst.2022039981","DOIUrl":"https://doi.org/10.1615/CritRevTherDrugCarrierSyst.2022039981","url":null,"abstract":"<p><p>The emergence of multidrug-resistant (MDR) and extremely drug resistant (XDR) forms of pulmonary tuberculosis (TB) remains a major health challenge in this advanced era of health science. The longer therapy and higher dose of anti-tubercular drugs (ATDs) increases the patient incompliance at its peak levels of intolerance as well as toxicity. In the recent decades, nanoparticulate drug delivery has emerged as an excellent venture for the effective treatment of cancer, infectious diseases, brain as well as TB. Currently, encapsulation and conjugation of therapeutics to polymeric nanoparticles (PNPs) is an attractive strategy to enhance the effectivity of chemotherapeutics and minimize the toxic effects associated with ATDs. Various characteristics of nanoparticles (NPs) such as high stability, high loading efficiency, and high carrying capacity gives preference to the NPs over other drug delivery systems. Multiple or dual drug delivery concept is continuously gaining attention as a strict and favourable requirement of anti-TB therapy. The ideal properties of NPs including controlled or sustained drug release from the matrix enhances drug bioavailability with dose reduction and also enhance compliance of TB patients. Natural and synthetic polymers are playing important role in curtailing the side effects of chemotherapeutics. This review extensively highlights the drug delivery approaches of ATDs and emphasized on the importance and application of PNPs to combat TB.</p>","PeriodicalId":50614,"journal":{"name":"Critical Reviews in Therapeutic Drug Carrier Systems","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40717502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Exploring Liposomes for Lung Cancer Therapy. 探讨脂质体在肺癌治疗中的应用。
IF 2.7 4区 医学 Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-01-01 DOI: 10.1615/critrevtherdrugcarriersyst.2021037912
Aisha Shahid, M. M. Khan, Usama Ahmad, M. Haider, Asad Ali
Cancer is referred to as a pleiotropic disease-causing approximately 9.6 million deaths in 2018. Among all cancers, lung cancer was the leading cause of death in 2017, and 12% of fatalities were alone due to lung cancer. The associated risk factors in lung cancer include smoking (80-85%), chronic inflammation in the lungs, COPD, pulmonary fibrosis, environmental and occupational exposure to nickel, arsenic, chromates, etc. Early diagnosed patients' treatment plan includes chemotherapy, immunotherapy, radiotherapy, surgery, and tumor ablation. Many sorts of drug delivery carriers have been used in the past, usually in targeted chemotherapy. Liposomes are spherical shape vesicles containing a lipid bilayer and aqueous core, with potency to encapsulate both hydrophobic and hydrophilic drugs with minimal toxicity. These vesicles have a particle size of 0.02-1000 μm allowing selective passive targeting to the tumor's deeper tissues. Current publications on liposomes highlight their acceptance and best choice among all systems to deliver synthetic and herbal drugs to the lungs. This review focuses on many aspects, which include an in-depth analysis of potential anticancer drugs that have utilized the advantages of liposomes for effective lung carcinomatherapy and devices used to deliver the active agents to the pulmonary tissues. Investigations on ongoing, approved, and failed clinical trials and patents on products related to lung cancer have been highlighted to provide a critical review on the subject.
癌症被称为一种多效性疾病,2018年导致约960万人死亡。在所有癌症中,肺癌是2017年死亡的主要原因,12%的死亡是由肺癌引起的。肺癌的相关危险因素包括吸烟(80-85%)、肺部慢性炎症、慢性阻塞性肺病、肺纤维化、环境和职业接触镍、砷、铬酸盐等。早期诊断患者的治疗方案包括化疗、免疫治疗、放疗、手术和肿瘤消融。在过去,通常在靶向化疗中使用了多种药物递送载体。脂质体是一种含有脂质双分子层和水核的球形囊泡,具有包封疏水和亲水药物的能力,毒性最小。这些囊泡的粒径为0.02-1000 μm,可以选择性地被动靶向肿瘤的深层组织。目前关于脂质体的出版物强调了它们在所有将合成药物和草药输送到肺部的系统中的可接受性和最佳选择。本文从多个方面进行综述,其中包括深入分析利用脂质体的优势进行有效肺癌治疗的潜在抗癌药物和用于将活性药物输送到肺组织的装置。对正在进行的、批准的和失败的肺癌相关产品临床试验和专利的调查已被强调,以提供对该主题的批判性审查。
{"title":"Exploring Liposomes for Lung Cancer Therapy.","authors":"Aisha Shahid, M. M. Khan, Usama Ahmad, M. Haider, Asad Ali","doi":"10.1615/critrevtherdrugcarriersyst.2021037912","DOIUrl":"https://doi.org/10.1615/critrevtherdrugcarriersyst.2021037912","url":null,"abstract":"Cancer is referred to as a pleiotropic disease-causing approximately 9.6 million deaths in 2018. Among all cancers, lung cancer was the leading cause of death in 2017, and 12% of fatalities were alone due to lung cancer. The associated risk factors in lung cancer include smoking (80-85%), chronic inflammation in the lungs, COPD, pulmonary fibrosis, environmental and occupational exposure to nickel, arsenic, chromates, etc. Early diagnosed patients' treatment plan includes chemotherapy, immunotherapy, radiotherapy, surgery, and tumor ablation. Many sorts of drug delivery carriers have been used in the past, usually in targeted chemotherapy. Liposomes are spherical shape vesicles containing a lipid bilayer and aqueous core, with potency to encapsulate both hydrophobic and hydrophilic drugs with minimal toxicity. These vesicles have a particle size of 0.02-1000 μm allowing selective passive targeting to the tumor's deeper tissues. Current publications on liposomes highlight their acceptance and best choice among all systems to deliver synthetic and herbal drugs to the lungs. This review focuses on many aspects, which include an in-depth analysis of potential anticancer drugs that have utilized the advantages of liposomes for effective lung carcinomatherapy and devices used to deliver the active agents to the pulmonary tissues. Investigations on ongoing, approved, and failed clinical trials and patents on products related to lung cancer have been highlighted to provide a critical review on the subject.","PeriodicalId":50614,"journal":{"name":"Critical Reviews in Therapeutic Drug Carrier Systems","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67437479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
[Novel strategies using sagacious targeting for site-specific drug delivery in breast cancer treatment: Clinical potentials and applications] [在乳腺癌治疗中使用靶向性靶向给药的新策略:临床潜力和应用]
IF 2.7 4区 医学 Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-01-01 DOI: 10.1615/critrevtherdrugcarriersyst.2022043898
P. Ebrahimnejad, Zahra Mohammadi, Melika Ahmadi, Shervin Amirkhanloo, A. Babaei, K. Asare-Addo, A. Nokhodchi
{"title":"[Novel strategies using sagacious targeting for site-specific drug delivery in breast cancer treatment: Clinical potentials and applications]","authors":"P. Ebrahimnejad, Zahra Mohammadi, Melika Ahmadi, Shervin Amirkhanloo, A. Babaei, K. Asare-Addo, A. Nokhodchi","doi":"10.1615/critrevtherdrugcarriersyst.2022043898","DOIUrl":"https://doi.org/10.1615/critrevtherdrugcarriersyst.2022043898","url":null,"abstract":"","PeriodicalId":50614,"journal":{"name":"Critical Reviews in Therapeutic Drug Carrier Systems","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67437635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Grafting of Natural Polymers and Gums for Drug Delivery Applications: A Perspective Review. 天然聚合物和树胶接枝在药物传递应用中的研究进展。
IF 2.7 4区 医学 Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-01-01 DOI: 10.1615/CritRevTherDrugCarrierSyst.2022035905
Baburao N Chandakavathe, Ravindra G Kulkarni, Shivsharan B Dhadde

Natural polymers have received more attention because of their advantages over synthetic polymers such as abundant availability, low cost, biodegradability and non-toxicity. However, natural polymers suffer some limitations such as drop-in viscosity upon storage, uncontrolled hydration, solubility, inability to perform under high temperature and pressure (thermal stability), etc. In many instances above mentioned drawbacks of natural polymers limits their applications in drug delivery systems. Grafting of natural polymer leads to improved properties and characteristics of backbones of macromolecules such as improvement in gel strength, swelling index, mucoadhesion, drug targeting and drug release profile. Therefore, in recent decades grafting of the natural polymer has gained immense importance for the development of drug delivery systems. In addition to the pharmaceutical applications graft copolymers are extensively utilized in diversified fields. The present review is an attempt to define the grafting, various methods of polymer grafting and their application in drug delivery.

天然聚合物因其相对于合成聚合物具有可利用性丰富、成本低、可生物降解和无毒等优点而受到越来越多的关注。然而,天然聚合物有一些限制,如储存时粘度下降,水化不受控制,溶解度,不能在高温高压下发挥作用(热稳定性)等。在许多情况下,上述天然聚合物的缺点限制了它们在药物输送系统中的应用。天然聚合物的接枝可以改善大分子骨架的性能和特征,如凝胶强度、膨胀指数、黏附、药物靶向性和药物释放谱等。因此,近几十年来,天然聚合物的接枝对于药物输送系统的发展具有巨大的重要性。除制药应用外,接枝共聚物还广泛应用于各种领域。本文综述了聚合物接枝的定义、各种接枝方法及其在给药中的应用。
{"title":"Grafting of Natural Polymers and Gums for Drug Delivery Applications: A Perspective Review.","authors":"Baburao N Chandakavathe,&nbsp;Ravindra G Kulkarni,&nbsp;Shivsharan B Dhadde","doi":"10.1615/CritRevTherDrugCarrierSyst.2022035905","DOIUrl":"https://doi.org/10.1615/CritRevTherDrugCarrierSyst.2022035905","url":null,"abstract":"<p><p>Natural polymers have received more attention because of their advantages over synthetic polymers such as abundant availability, low cost, biodegradability and non-toxicity. However, natural polymers suffer some limitations such as drop-in viscosity upon storage, uncontrolled hydration, solubility, inability to perform under high temperature and pressure (thermal stability), etc. In many instances above mentioned drawbacks of natural polymers limits their applications in drug delivery systems. Grafting of natural polymer leads to improved properties and characteristics of backbones of macromolecules such as improvement in gel strength, swelling index, mucoadhesion, drug targeting and drug release profile. Therefore, in recent decades grafting of the natural polymer has gained immense importance for the development of drug delivery systems. In addition to the pharmaceutical applications graft copolymers are extensively utilized in diversified fields. The present review is an attempt to define the grafting, various methods of polymer grafting and their application in drug delivery.</p>","PeriodicalId":50614,"journal":{"name":"Critical Reviews in Therapeutic Drug Carrier Systems","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40649107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
The Role of Polymers and Excipients for Better Gastric Retention of Captopril. 聚合物和赋形剂对卡托普利胃潴留的作用。
IF 2.7 4区 医学 Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-01-01 DOI: 10.1615/CritRevTherDrugCarrierSyst.2022042122
Uddipta Das, Pankaj Wadhwa, Pankaj Kumar Singh, Dheeraj Varma Kalidindi, Kalpana Nagpal

Captopril is an angiotensin-converting enzyme (ACE) inhibitor that prevents angiotensin I (ATI) from being converted to angiotensin II (ATII). However, it offers certain limitations like instability, dose dumping and burst release due to its usage in the native state. In the last two decades, different polymers and excipients have been used to make captopril more accessible and well-accepted. The present work discusses the efforts made by various scientists so far to make the oral administration of captopril more acceptable by overcoming its limitations. The different factors affecting gastric retention, approaches to achieve better gastric retention. The oral managed release dosage forms have enormous curative benefits such as improved therapeutics and better patient compliance. The polymer based gastro-retentive drug delivery systems (GRDDS) include microspheres, soild inclusion complex, floating tablets, alginate based beads, etc utilizes better retention in the stomach for longer duration of action and improved bioavailability. Overall, the work aims to summarize the attempts made as novel drug delivery approaches over the last two decades in reverse chronological order to make captopril more gastro retentive and orally acceptable by the patients.

卡托普利是一种血管紧张素转换酶(ACE)抑制剂,可防止血管紧张素I (ATI)转化为血管紧张素II (ATII)。然而,由于其在原生状态下使用,具有一定的不稳定性、剂量倾倒和突发释放等局限性。在过去的二十年里,不同的聚合物和赋形剂被用来使卡托普利更容易获得和被广泛接受。目前的工作讨论了各种科学家迄今所做的努力,通过克服口服卡托普利的局限性,使其更容易被接受。探讨影响胃潴留的不同因素,实现更好胃潴留的途径。口服控释剂型具有巨大的疗效,如改善治疗和更好的患者依从性。基于聚合物的胃保留性药物递送系统(GRDDS)包括微球、固体包合物、浮片、海藻酸盐基微球等,它们在胃中有更好的保留,作用时间更长,提高了生物利用度。总的来说,这项工作的目的是总结在过去的二十年中,以倒叙的时间顺序,作为新的药物递送方法的尝试,使卡托普利更具胃潴留性和口服可接受的患者。
{"title":"The Role of Polymers and Excipients for Better Gastric Retention of Captopril.","authors":"Uddipta Das,&nbsp;Pankaj Wadhwa,&nbsp;Pankaj Kumar Singh,&nbsp;Dheeraj Varma Kalidindi,&nbsp;Kalpana Nagpal","doi":"10.1615/CritRevTherDrugCarrierSyst.2022042122","DOIUrl":"https://doi.org/10.1615/CritRevTherDrugCarrierSyst.2022042122","url":null,"abstract":"<p><p>Captopril is an angiotensin-converting enzyme (ACE) inhibitor that prevents angiotensin I (ATI) from being converted to angiotensin II (ATII). However, it offers certain limitations like instability, dose dumping and burst release due to its usage in the native state. In the last two decades, different polymers and excipients have been used to make captopril more accessible and well-accepted. The present work discusses the efforts made by various scientists so far to make the oral administration of captopril more acceptable by overcoming its limitations. The different factors affecting gastric retention, approaches to achieve better gastric retention. The oral managed release dosage forms have enormous curative benefits such as improved therapeutics and better patient compliance. The polymer based gastro-retentive drug delivery systems (GRDDS) include microspheres, soild inclusion complex, floating tablets, alginate based beads, etc utilizes better retention in the stomach for longer duration of action and improved bioavailability. Overall, the work aims to summarize the attempts made as novel drug delivery approaches over the last two decades in reverse chronological order to make captopril more gastro retentive and orally acceptable by the patients.</p>","PeriodicalId":50614,"journal":{"name":"Critical Reviews in Therapeutic Drug Carrier Systems","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40649109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Cissus quadrangularis in the Management of Osteoporosis: An Overview. 四角肌在骨质疏松症治疗中的作用综述。
IF 2.7 4区 医学 Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2021-01-01 DOI: 10.1615/CritRevTherDrugCarrierSyst.2021033808
Jaspreet Kaur, Gajanand Sharma, Akanksha Mahajan, Om Parkash Katare, Sanjay Kumar Bhadada, Gargi Ghoshal

This article aims to provide a comprehensive review of Cissus quadrangularis (CQ), which is a traditional medicinal herb and has a potential osteoprotective effect. CQ is a perennial climber of family Vitaceae that is commonly found in the hotter parts of India. It is most widely used in India for improving bone health and is well known as "hadjod." It shows an anti-osteoporotic effect through different pathways mechanisms. It is natural matrices of excellence with proven bioactivity. Several cell line and animal studies demonstrated its protective nature against many diseases such as osteoporosis, arthritis, gastric ulcers etc. This review also highlights the phytochemicals identified to the date and related pharmacological applications. The discussion has also expanded to its oral formulations, which has been proven for its efficacy practically. However, the scientific information of CQ is not in the proper documentation for reference, and so availability of scientific knowledge of this climber is limited. Therefore, this review might be provided a platform to those who will be interested in studying further this herb, either for analyzing phytochemical profiling or its anti-osteoporotic usage. This is a crucial platform as several productive results have been reported on this herb, which likely to be beneficial for new drug discovery in future. Here we also discuss the bone remodeling and related factors influenced by the intake of CQ.

本文旨在对具有潜在骨保护作用的传统中草药——四角草(CQ)进行综述。CQ是一种常见于印度较热地区的维塔科多年生攀援植物。它在印度被广泛用于改善骨骼健康,被称为“hadjod”。它通过不同的途径和机制显示出抗骨质疏松的作用。它是卓越的天然基质,具有已证实的生物活性。一些细胞系和动物研究表明,它对骨质疏松症、关节炎、胃溃疡等多种疾病具有保护作用。本文还重点介绍了迄今为止已鉴定的植物化学物质及其药理应用。讨论还扩大到其口服配方,其实际功效已得到证明。然而,CQ的科学信息并没有在适当的文献中可供参考,因此对这位登山者的科学知识的可用性是有限的。因此,这一综述可能为那些有兴趣进一步研究这种草药的人提供一个平台,无论是分析植物化学特征还是其抗骨质疏松的用途。这是一个重要的平台,因为已经报道了一些关于这种草药的富有成效的结果,这可能对未来的新药发现有益。本文还讨论了CQ摄入对骨重塑及相关因素的影响。
{"title":"Role of Cissus quadrangularis in the Management of Osteoporosis: An Overview.","authors":"Jaspreet Kaur,&nbsp;Gajanand Sharma,&nbsp;Akanksha Mahajan,&nbsp;Om Parkash Katare,&nbsp;Sanjay Kumar Bhadada,&nbsp;Gargi Ghoshal","doi":"10.1615/CritRevTherDrugCarrierSyst.2021033808","DOIUrl":"https://doi.org/10.1615/CritRevTherDrugCarrierSyst.2021033808","url":null,"abstract":"<p><p>This article aims to provide a comprehensive review of Cissus quadrangularis (CQ), which is a traditional medicinal herb and has a potential osteoprotective effect. CQ is a perennial climber of family Vitaceae that is commonly found in the hotter parts of India. It is most widely used in India for improving bone health and is well known as \"hadjod.\" It shows an anti-osteoporotic effect through different pathways mechanisms. It is natural matrices of excellence with proven bioactivity. Several cell line and animal studies demonstrated its protective nature against many diseases such as osteoporosis, arthritis, gastric ulcers etc. This review also highlights the phytochemicals identified to the date and related pharmacological applications. The discussion has also expanded to its oral formulations, which has been proven for its efficacy practically. However, the scientific information of CQ is not in the proper documentation for reference, and so availability of scientific knowledge of this climber is limited. Therefore, this review might be provided a platform to those who will be interested in studying further this herb, either for analyzing phytochemical profiling or its anti-osteoporotic usage. This is a crucial platform as several productive results have been reported on this herb, which likely to be beneficial for new drug discovery in future. Here we also discuss the bone remodeling and related factors influenced by the intake of CQ.</p>","PeriodicalId":50614,"journal":{"name":"Critical Reviews in Therapeutic Drug Carrier Systems","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39298206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
期刊
Critical Reviews in Therapeutic Drug Carrier Systems
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1